Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography.
heart
juvenile systemic sclerosis
outcome measures
scleroderma
severity score
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
05 01 2021
05 01 2021
Historique:
received:
07
01
2020
accepted:
26
03
2020
pubmed:
24
6
2020
medline:
20
4
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
Cardiac involvement is the most important cause of mortality in juvenile systemic sclerosis (JSSc). Recent reports in adult patients underline that traditional techniques of imaging are inadequate to assess the subclinical cardiac involvement, while speckle tracking echocardiography (STE) is able to identify ventricular dysfunctions in the early stages. The aim of our study was to assess the role of STE in JSSc. Demographic, clinical and laboratory data were collected from patients with JSSc. Cardiac investigations performed at baseline (T0) and 18 (T18) and 36 months (T36) follow-up included electrocardiography, conventional echocardiography with measurement of the ejection fraction (EF) and STE with assessment of left and right ventricular global longitudinal strain (LV-GLS and RV-GLS). Cardiac parameters have been compared with demographic characteristics and disease severity, assessed by the Juvenile Systemic Sclerosis Severity Score (J4S). A total of 18 patients, 12 (67%) females, entered the study. At T0, electrocardiography was abnormal in three patients, EF was reduced in one, LV-GLS was abnormal in three (16.7%) and RV-GLS was abnormal in five (27.8%). At T18, EF remained stable while at T36 the result decreased in seven of nine patients. At the same time, LV-GLS also worsened (from -21.6% to -18.2%, P = 0.01). LV-GLS and RV-GLS at baseline showed a significant correlation with J4S (P = 0.012 and P = 0.02, respectively). STE is more sensitive than standard echocardiography to identify cardiac involvement in JSSc. Over time, we observed a gradual worsening of LV-GLS, a sign of left ventricular dysfunction, that anticipated by several months the decrease of EF.
Identifiants
pubmed: 32572491
pii: 5861025
doi: 10.1093/rheumatology/keaa208
pmc: PMC7785305
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-107Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
Biomed Res Int. 2016;2016:9363951
pubmed: 26942202
Semin Arthritis Rheum. 2014 Feb;43(4):526-35
pubmed: 23932313
J Clin Invest. 2007 Mar;117(3):557-67
pubmed: 17332883
Arthritis Rheum. 2007 Mar 15;57(2):203-12
pubmed: 17330294
Rheumatology (Oxford). 2009 Feb;48(2):119-22
pubmed: 18854345
PLoS One. 2016 Dec 29;11(12):e0168109
pubmed: 28033331
Arthritis Rheum. 2006 Dec;54(12):3971-8
pubmed: 17133611
Arthritis Rheum. 2012 Dec;64(12):4143-50
pubmed: 22886849
Best Pract Res Clin Rheumatol. 2017 Aug;31(4):576-595
pubmed: 29773274
Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):863-70
pubmed: 22427402
Pediatr Cardiol. 2017 Dec;38(8):1686-1695
pubmed: 28913656
Cardiovasc Ultrasound. 2014 Mar 29;12:13
pubmed: 24678809
J Am Soc Echocardiogr. 2012 Jul;25(7):733-40
pubmed: 22578518
Front Immunol. 2019 Jun 25;10:1352
pubmed: 31293569
Cardiovasc Ultrasound. 2013 Feb 03;11:6
pubmed: 23374960
Echo Res Pract. 2015 Mar 1;2(1):G9-G24
pubmed: 26693316
Rheum Dis Clin North Am. 2008 Feb;34(1):181-90; viii
pubmed: 18329539
Arthritis Rheum. 2011 Dec;63(12):3969-78
pubmed: 22127711
Eur J Prev Cardiol. 2018 Oct;25(15):1598-1606
pubmed: 29966435